In conclusion, given the critical role of BCSCs in conferring chemoresistance, enhancement of IL-6 to BCSCs population reveals the clew of that it can promote the resistance of breast cancer cells to chemotherapeutic drugs [34]. The gene discussed is IL6; the disease is breast carcinoma.